VistaGen Therapeutics
VTGN
#9237
Rank
$67.1 M
Marketcap
$2.41
Share price
-0.82%
Change (1 day)
-53.56%
Change (1 year)

VistaGen Therapeutics (VTGN) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : $9.52 Million USD

According to VistaGen Therapeutics 's latest financial reports the company's total liabilities are $9.52 Million USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

VistaGen Therapeutics - Total liabilities on balance sheet (from 2008 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-03-31$9 M-9.26%
2022-03-31$9.92 M-39.1%
2021-03-31$16.3 M41.74%
2020-03-31$11.5 M65.81%
2019-03-31$6.93 M59.03%
2018-03-31$4.36 M40.86%
2017-03-31$3.09 M-21.95%
2016-03-31$3.96 M-80.94%
2015-03-31$20.81 M59.32%
2014-03-31$13.06 M-2.79%
2013-03-31$13.43 M122.22%
2012-03-31$6.04 M
2010-12-31$0 M113.33%
2009-12-31$0 M-44.15%
2008-12-31$0 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
$28.07 M 194.85%๐Ÿ‡บ๐Ÿ‡ธ USA